Published in Contraception on January 03, 2006
Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects. Int J Mol Sci (2010) 0.94
Family Planning Practices, Programmes and Policies in India Including Implants and Injectables with a Special Focus on Jharkhand, India: A Brief Review. J Clin Diagn Res (2015) 0.75
Family planning: the unfinished agenda. Lancet (2006) 8.65
Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet (2006) 6.56
Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study. BMJ (2007) 4.92
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain (2008) 2.91
Methodological considerations in implementing the WHO Global Survey for Monitoring Maternal and Perinatal Health. Bull World Health Organ (2008) 2.15
Maternal near miss and maternal death in the World Health Organization's 2005 global survey on maternal and perinatal health. Bull World Health Organ (2009) 1.90
Intervention to reduce catheter-related bloodstream infections in a pediatric intensive care unit. Intensive Care Med (2011) 1.58
Intracluster correlation coefficients from the 2005 WHO Global Survey on Maternal and Perinatal Health: implications for implementation research. Paediatr Perinat Epidemiol (2008) 1.56
An alternative echocardiographic method to estimate mean pulmonary artery pressure: diagnostic and clinical implications. J Am Soc Echocardiogr (2009) 1.54
Development of the Post Cardiac Surgery (POCAS) prognostic score. Crit Care (2013) 1.40
Retrospective evaluation of the effectiveness of epsilon aminocaproic acid for the prevention of postamputation bleeding in retired racing Greyhounds with appendicular bone tumors: 46 cases (2003-2008). J Vet Emerg Crit Care (San Antonio) (2012) 1.37
Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care (2007) 1.32
Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors. BMC Mol Biol (2007) 1.13
Understanding the factors associated with differences in caesarean section rates at hospital level: the case of Latin America. Paediatr Perinat Epidemiol (2009) 1.06
Contraceptive vaginal rings: a review. Contraception (2010) 1.04
Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. J Pharm Sci (2009) 0.97
A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. J Clin Endocrinol Metab (2003) 0.93
Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women. Hum Reprod (2002) 0.92
Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception. Contraception (2005) 0.89
Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease. Mayo Clin Proc (2007) 0.88
Neosaxitoxin as a local anesthetic: preliminary observations from a first human trial. Anesthesiology (2007) 0.87
Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial. Contraception (2005) 0.86
Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women. Contraception (2011) 0.86
Curve of amniotic fluid index measurements in low-risk pregnancy. Acta Obstet Gynecol Scand (2007) 0.85
Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception. Contraception (2007) 0.84
Evaluating the clinical safety of three vaginal applicators: a pilot study conducted in the Dominican Republic. Contraception (2005) 0.83
Mechanical complications during central venous cannulations in pediatric patients. Intensive Care Med (2009) 0.82
Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention. Eur Heart J (2009) 0.81
Enhancing and sustaining AMG 009 dissolution from a matrix tablet via microenvironmental pH modulation and supersaturation. AAPS PharmSciTech (2011) 0.81
Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception. Contraception (2007) 0.80
Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen. Contraception (2005) 0.80
TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age. Contraception (2005) 0.79
Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product. Contraception (2006) 0.79
[C677T polymorphism of the methylentetrahydrofolate reductase gene as risk factor in women with recurrent abortion]. Invest Clin (2009) 0.79
Premenstrual asthma and atopy markers. Ann Allergy Asthma Immunol (2010) 0.79
Malignant fibrous histiocytoma of the lung presenting as bronchial obstruction in a heart transplant recipient. J Heart Lung Transplant (2002) 0.78
Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study. Contraception (2008) 0.77
Doses of levonorgestrel comparable to that delivered by the levonorgestrel-releasing intrauterine system can modify the in vitro expression of zona binding sites of human spermatozoa. Contraception (2005) 0.77
Competencies in pulmonary procedures. Chest (2004) 0.77
[Recommendations for antibiotic monitoring in ICU patients]. Farm Hosp (2008) 0.77
Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study. Metabolism (2008) 0.76
Safety of percutaneous dilatational tracheostomy with direct bronchoscopic guidance for solid organ allograft recipients. Mayo Clin Proc (2007) 0.76
Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women. Contraception (2004) 0.76
The manufacture of low-dose oral solid dosage form to support early clinical studies using an automated micro-filing system. AAPS PharmSciTech (2010) 0.75
Enhancing and sustaining AMG 009 dissolution from a bilayer oral solid dosage form via microenvironmental pH modulation and supersaturation. AAPS PharmSciTech (2011) 0.75
Evaluating and modifying Johanson's rolling model to improve its predictability. J Pharm Sci (2014) 0.75
Fatal liver failure: molecular evidence for chronic active Epstein-Barr virus infection. Ann Diagn Pathol (2007) 0.75
Fatal arterial gas embolism in an adult 1 year after bilateral sequential lung transplantation. J Heart Lung Transplant (2008) 0.75
Misoprostol: life-saving. Eur J Contracept Reprod Health Care (2011) 0.75
Cardiopulmonary exercise testing with pulmonary artery catheterization detects early pulmonary vasculature changes in patients with connective tissue diseases. J Clin Rheumatol (2002) 0.75
Uteroplacental circulation during the first trimester of normal and abnormal pregnancy. Reprod Biomed Online (2002) 0.75
Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen. Contraception (2005) 0.75
[Indirect prenatal molecular diagnostic of haemophilia A and B]. Invest Clin (2008) 0.75
Next generation sequencing search for uromodulin gene variants related with impaired renal function. Mol Biol Rep (2015) 0.75